+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioactive Wound Management - Global Market Trajectory & Analytics

  • ID: 5309889
  • Report
  • April 2021
  • Region: Global
  • 152 pages
  • Global Industry Analysts, Inc
Global Bioactive Wound Management Market to Reach $2.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 11.2% over the analysis period 2020-2027. Xenografts, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$554.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Allografts segment is readjusted to a revised 12.3% CAGR for the next 7-year period.



The U.S. Market is Estimated at $395.4 Million, While China is Forecast to Grow at 10.7% CAGR

The Bioactive Wound Management market in the U.S. is estimated at US$395.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$492 Million by the year 2027 trailing a CAGR of 10.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.8% and 9.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Bioengineered Skin Substitutes Segment to Record 11% CAGR

In the global Bioengineered Skin Substitutes segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$194.4 Million in the year 2020 will reach a projected size of US$398.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$330.5 Million by the year 2027.

Select Competitors (Total 44 Featured):
  • 3M Company
  • Acelity LP, Inc.
  • ACell Inc.
  • Convatec Group PLC
  • Covalon Technologies Ltd.
  • Integra LifeSciences Holdings Corporation
  • MiMedx Group, Inc.
  • Smith & Nephew PLC
  • SYMATESE
  • Wright Medical Group NV
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Bioengineered Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Collagen-based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Collagen-based Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Topical Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Topical Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Venous Leg Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Diabetic Foot Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Pressure Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Surgical Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 21: World Current & Future Analysis for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 22: World 7-Year Perspective for Burn Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 23: USA Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • CANADA
  • Table 27: Canada Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • JAPAN
  • Table 31: Japan Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 33: Japan Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • CHINA
  • Table 35: China Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: China 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 37: China Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: China 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • EUROPE
  • Table 39: Europe Current & Future Analysis for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 40: Europe 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 41: Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 43: Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • FRANCE
  • Table 45: France Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 46: France 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 47: France Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: France 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • GERMANY
  • Table 49: Germany Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Germany 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 51: Germany Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Germany 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • ITALY
  • Table 53: Italy Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: Italy 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 55: Italy Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: Italy 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 57: UK Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: UK 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 59: UK Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: UK 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 61: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Rest of Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 63: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 64: Rest of Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 65: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 67: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
  • REST OF WORLD
  • Table 69: Rest of World Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 70: Rest of World 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
  • Table 71: Rest of World Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 72: Rest of World 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll